EconPapers    
Economics at your fingertips  
 

The EC Pharmaceutical Inquiry: Behind the Headlines, What is the Real Story on Innovation and Generic Competition in Pharmaceuticals?

Thomas Cueni

Antitrust Chronicle, 2008, vol. 11

Abstract: While the pharmaceutical sector waits for the European Commission’s interim report and hearing scheduled for November 28, 2008, there is an opportunity to step back and examine critically the premise of the inquiry started infamously with dawn raids on January 16, 2008 that, as Commissioner Kroes announced, “if innovative products are not being produced, and cheaper generic alternatives … delayed, then we need to find out why and, if necessary, take action.â€Â

Date: 2008
References: Add references at CitEc
Citations: Track citations by RSS feed

Downloads: (external link)
http://www.competitionpolicyinternational.com/the- ... n-in-pharmaceuticals (application/pdf)
Requires login and subscription

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cpi:atchrn:11.1.2008:i=5163

Access Statistics for this article

More articles in Antitrust Chronicle from Competition Policy International
Bibliographic data for series maintained by Lindsay McSweeney (). This e-mail address is bad, please contact .

 
Page updated 2019-05-22
Handle: RePEc:cpi:atchrn:11.1.2008:i=5163